Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)-Reference-Cited by-同舟云学术

Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)

Published:2023-06-06 Issue:12 Volume:149 Page:10495-10503
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Franzese Ciro,Vernier Veronica,Franceschini Davide,Comito Tiziana,Navarria Pierina,Clerici Elena,Teriaca Maria Ausilia,Massaro Maria,Di Cristina Luciana,Marini Beatrice,Galdieri Carmela,Mancosu Pietro,Tomatis Stefano,Scorsetti Marta

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04964-z.pdf

Reference26 articles.

1. Ashram S, Bahig H, Barry A, Blanchette D, Celinksi A, Chung P et al (2022) Planning trade-offs for SABR in patients with 4 to 10 metastases: a substudy of the SABR-COMET-10 randomized trial. Int J Radiat Oncol Biol Phys 114:1011–1015. https://doi.org/10.1016/j.ijrobp.2022.05.035

2. Baschnagel AM, Meyer KD, Chen PY, Krauss DJ, Olson RE, Pieper DR et al (2013) Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgery. J Neurosurg 119:1139–1144. https://doi.org/10.3171/2013.7.JNS13431

3. Chalkidou A, Macmillan T, Grzeda MT, Peacock J, Summers J, Eddy S et al (2021) Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study. Lancet Oncol 22:98–106. https://doi.org/10.1016/S1470-2045(20)30537-4

4. Chmura S, Winter KA, Robinson C, Pisansky TM, Borges V, Al-Hallaq H et al (2021) Evaluation of safety of stereotactic body radiotherapy for the treatment of patients with multiple metastases. JAMA Oncol 7:845. https://doi.org/10.1001/jamaoncol.2021.0687

5. Decaestecker K, De Meerleer G, Lambert B, Delrue L, Fonteyne V, Claeys T et al (2014) Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence. Radiat Oncol 9:135. https://doi.org/10.1186/1748-717X-9-135